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Background. We present our centres successful endourological methodology of ex vivo ureteroscopy (EVFUS) in the management
of these kidneys prior to renal transplantation. Patient and Methods. A retrospective analysis was performed of all living donors
(n = 157) identiﬁed to have asymptomatic incidental renal calculi from January 2004 until December 2008. The incidence of
asymptomatic renal calculi was 3.2% (n = 5). Donors were subdivided into 2 groups depending on whether theydonated the
kidney with the renal calculus (Group 1) versus the opposite calculus-free kidney (Group 2). Results. All donors in Group 1
underwent a left laparoscopic donor nephrectomy. The calculi were extracted in all 3 cases using a 7.5Fr ﬂexible ureteroscope
either prior to transplant (n = 2) or on revascularization (n = 1). There were no urological complications in either group. At a
mean followup at 64 months there was no recurrent calculi formation in the recipient in Group 1. However, 1 recipient formed
a calculus in group 2 at a follow up of 72 months. Conclusions. Renal calculi can be successfully retrieved during living-related
transplantation at the time of transplant itself using EVUS. This is technically feasible and is associated with no compromise in
ureteral integrity or renal allograft function.
1.Introduction
Within the United Kingdom (UK), living-related donor
nephrectomies (LRDNs) are becoming common. The most
importantconstituentforasuccessfulLRDNandsubsequent
transplantsisthesynchronousmanagementofthedonorand
recipients by a multidisciplinary team approach involving
urologist, renal transplant surgeons, nephrologist, and radi-
ologist.
The long-term graft functions following living-related
renal transplant (LRRT) are superior in comparison to ca-
daveric transplantation at all ages, particularly in the very
young recipients [1, 2]. The incidence of LRRT varies from
country to country. In the UK the incidence was 16% [3],
whereasinNorthAmerica49%ofpaediatrictransplantstend
to be from living donors [2]. In Scandinavia the incidence
of LRRT is as high as 86% [4]. Within the UK a total of
1,140 people were approved to become living donors during
2009-2010; this was 92 more than the year before and up
from 342 in 2006-2007 which is a rise of 333% in four years
[5].
Urolithiasis in donor kidneys is a relatively uncommon
clinical entity and has an annual incidence of less than 1%
[6, 7]. Two decades ago, urolithiasis within the donor kidney
wasdeemedanabsolutecontraindicationfordonationasthis
was theoretically associated risk of postoperative allograft
dysfunction due to urolithiasis when transplanted into the
recipient [8]. From the donor’s perspective, there is also an
additional risk of future stone formation in the remaining
kidney which could lead to possible sequelae of urolithiasis
such as obstruction uropathy, urinary tract infections (UTI),
sepsis, and end-stage renal disease (ESRD) [9].
With the current advances in endourology and radio-
logical imaging, donor kidney urolithiasis can be accurately
assessed on preoperative computerized tomography (CT)
scans. The anatomy of the remaining kidney can also be2 ISRN Urology
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Figure 1: 7.5 Fr ﬂexible ureteroscope (a) being used for stone
extraction (b).
assessed for similar abnormalities. Current recommenda-
tions for incidentally diagnosed renal calculi in donors in-
clude a thorough metabolic screen to ensure that the kidney
is deemed suitable for transplantation if it contains a small
asymptomatic stone [10, 11]. The current strategies in the
literature for the management of urolithiasis in donor kid-
neys are preoperative treatment with extracorporeal shock
wave lithotripsy (ESWL) or percutaneous nephrolithotomy
(PCN) [12–16].
The decision as to whether the donor should be left with
the stone-bearing kidney or whether this kidney should be
usedasagraftforthetransplantisbasedonadetaileddiscus-
sion process involving the donor and the multidisciplinary
team of clinicians involved in the donor’s care which include
the urologist, renal transplant surgeons, nephrologist, and
radiologist.
We describe our successful endourological strategy of us-
ing an ex vivo 7.5 French (Fr) ﬂexible ureteroscope (EVFUS)
(Figure 1) and an Escape Nitinol Stone Retrieval Device
to successfully extract renal calculi at the time of renal
transplantation. We also review current additional strategies
in the management of these rare and challenging cases in the
current literature.
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Figure 2: Use of the ﬂexible ureteroscope in the Bench technique
(a) and On-Table technique (b).
2. Patients andMethods
A retrospective analysis was performed of all living donors
identiﬁed to have asymptomatic incidental renal calculi on
preoperative CT from January 2004 until December 2008.
At our centre we performed a total of 512 renal transplants
during this period amongst which 30.7% (n = 157) were
LRRT. Amongst this cohort the incidence of asymptomatic
renal calculi was 3.2% (n = 5).
The exact location, size, and anatomy of the kidney bear-
ing the stone were delineated prior to the planned LRDN. In
2 of the donors the opposite kidney was removed, and in the
remaining 3 donors stone extraction was performed using
a 7.5 Fr ﬂexible ureteroscope at the time of transplantation
using the following technique.
In our technique described, a 7.5 Fr ﬂexible ureteroscope
is placed into the graft ureter under low pressure irrigation
to achieve the renal calculus which is then extracted using
the Escape Nitinol Stone Retrieval Device. This technique is
the Bench technique and has the potential disadvantage of
prolonging warm ischemia time (WIT) (Figure 2(a)). The
modiﬁcation of the technique involves the use of the 7.5
Fr ﬂexible ureteroscope when the renal donor graft hasISRN Urology 3
been revascularized into the recipient (On-Table technique)
(Figure 2(b)).
3. Results
Amongst the 5 donors identiﬁed with asymptomatic urolith-
iasis, we used 3 of these kidneys for renal transplantation. In
the remaining 2 patients the kidneys with urolithiasis were
leftinsitu.Thedonorsthemselvesinboththesecasesdecided
againstdonatingtheirkidneywithurolithiasis.Inthissection
we divided these donors into those whodonated their kidney
with urolithiasis (Group 1, n = 3) and those who voluntarily
decided to donate their opposite kidney with no urolithiasis
(Group 2, n = 2).
The mean age of donors in Group 1 was47.6 years(range
46–50) and in Group 2 was 43.5 years (range 40–47) (P =
NS). The age of the recipients in Group 1 was 29.3 years
(range 22–51) and in Group 2 was 44 years (range 28–
60) (P = NS). There was no diﬀerence in preoperative
American Society of Anaesthesiologists (ASA) score and
Glomerular ﬁltration rate (GFR) or signiﬁcant diﬀerence in
splitrenalfunctionon[99mTc]-DTPArenographyindonors
within both groups. Donors in both groups had detailed
preoperative investigations for urolithiasis which included
serum biochemical analysis (ionized calcium, uric acid,
parathyroid hormone levels, and creatinine) and urinary
electrolyte analysis. All investigations in both groups were
normal.
Within Group 1, 3 donors were diagnosed with asymp-
tomatic urolithiasis present within their left kidney. The
calculi were lower pole (n = 2) and mid pole (n = 1) in
the left kidney. The mean size of the renal calculi identiﬁed
was 3.6mm (range 3–5). The mean split function on the
preoperative renogram was 49% (range of the left kidney
46–53). Following donor nephrectomy, these calculi were
extracted using our technique described using the 7.5 Fr
ﬂexible ureteroscope and the “Bench technique” in 1 renal
graft prior to transplant with a WIT of 5 minutes. In
the remaining 2 cases the calculi were extracted using the
“On-Table” technique. Biochemical analysis of the extracted
calculi conﬁrmed calcium oxalate with a mean composition
of80%andcalciumphosphateof20%.Theviewofthemajor
calyx before and after stone extraction is demonstrated in
Figure 3. At a mean followup of 64 months (range 48–84)
both the donor and recipients are stone free. Additionally,
there were no complications in the graft function and more
importantly no urological complications such as ischemic
strictures, anastomotic stenosis, or urinary leak.
In Group 2, both patients were diagnosed with right-
sided asymptomatic urolithiasis and voluntary donated their
left kidney after detailed counselling. The initial recipient in
this group developed a renal calculus measuring 7 × 2mm
requiring a ureteroscopic stone extraction at 48-month fol-
lowup. Biochemical analysis of the extracted calculus con-
ﬁrmed a composition of calcium phosphate 77% and cal-
cium oxalate 23%. At a further followup of 60 months from
initial transplant and 12 months following ureteroscopic
stone extract, the recipient is stone-free. The remaining
Renal calculus
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Figure 3: Flexible ureteroscopic view of calculi within the renal
donor graft before (a) and after extraction (b).
recipient in this group is stone-free at a followup of 72
months following transplant.
4. Discussion
Urolithiasis is common and can be asymptomatic in donors.
Our ex vivo ureteroscopic management of asymptomatic
calculi using the ﬂexible ureteroscope and stone retrieval
using the Escape Nitinol Stone Retrieval Device is safe, suc-
cessful, and associated with no long-term graft-related
complications or urological complications which include
ischemic/anastomotic strictures or urinary leak on trans-
plantation.
In LRRT the donor’s long-term health is of utmost pri-
ority. The current literature suggests that the incidence of
stone progression in patients with asymptomatic calculi can
be as high as 77% with the need for urological intervention
being 26% [17]. Hence, it is important to evaluate donors
with asymptomatic renal calculi for metabolic abnormalities
in order to correct these and prevent the further risk of renal
calculi formation. Those donors who are not at a proven risk
for recurrent stone formation may be suitable for donating
their kidney with renal calculus if the current stone is less
than 15mm and the kidney is anatomically suitable for
transplantation [17–19].
In our series, one recipient developed a further calculus
despitehavinganon-stone-bearingkidneytransplanted.The
incidence of renal calculus formation following renal trans-
plantation in recipients is approximately 5-6% [20]. In this4 ISRN Urology
series a cohort of 710 renal transplant recipients were eval-
uated for the risk transplant graft renal calculus formation
over a duration of 4 years. The incidence of renal calculus
formation within this cohort was 6% (44). Interestingly, a
renal calculus disease in the donors was a contraindication
to using the kidney during renal transplantation within this
series [20].
Van Gansbeke et al. reported on one donor who devel-
oped allograft failure secondary to renal calculus formation
[8]. Qazi et al. discuss two cases which also developed renal
calculiwithintheirrenalgraftfollowingtransplantation[18].
All three cases [8, 18] required emergency surgical interven-
tion, and none of the cases were associated with long-term
urological complication or graft failure. There is particular
concern regarding renal graft calculus formation as these can
bediﬃculttodiagnoseaspatientsdonotpresentwithtypical
symptoms of “loin to groin” pain when they develop. The
manifestations can present a few days or weeks following
the onset of calculi formation which includes severe sepsis
secondary to obstructive uropathy or loss of graft function
in severe cases, ureteral stricture, or urinary tract infection
[12, 14, 15, 19]. Postoperative allograft dysfunction as result
of an obstructive uropathy can be delayed with potentially
disastrous, and yet avoidable, consequences.
In previous studies stones have been managed in the
postoperative period using ESWLorPCNpriortotransplant
[12–16]. These techniques are advocated to be a safe and
satisfactory approach in these papers. However, both tech-
niques are associated with the risk of stone-associated
complications in the early postoperative period, which could
be potentially avoided if the stones had been removed prior
to implantation.
There are also possible diﬃculties associated with ESWL
on a transplanted kidney, as found by Bhadauria et al. [19].
The authors commented on diﬃculty in localising calculi or
small residual fragments accurately prior to transplant. In
thisseriesahighresidualstonerate(25to40%)wasnotedfor
lower caliceal stones, whilst periureteral ﬁbrosis was thought
to be associated with making the ureter less pliable and thus
manipulationwithsubsequentpossibleEVFUSdiﬃcult[19].
Rashid et al. described 10 cases of EVFUS for the treat-
ment of donor calculi [9]. The authors found the technique
easier as the removed kidney no longer exhibited the normal
anatomical narrowing of the ureter at the iliac vessels and
the ureterovesical junction. Furthermore the kidney could
be manipulated to allow easier access to all the calices. In
their study all but one stone was successfully treated and/or
removed, with diameters ranging from 1 to 8mm. No intra-
operative or postoperative complications were experienced.
There was no stone recurrence in donors (average followup
of 36.4 months) or recipients (33.2), as well as no delayed
ureteral stricture formation.
Trivedi et al. had an equally successful experience with
EVFUS in 3 cases [21]. Although one patient required
posttransplantation ESWL for migration of a small lower
calicealcalculusintotheupperureterfoundonpostoperative
imaging,therewerenosigniﬁcantureteralcomplicationsand
at mean followup of 2.2 years no new stone had formed in
either the recipient or donor.
For donors who have suﬀered from calculi due to
pelviureteric junction obstruction, resulting in persisting
hydronephrosis, there is the additional management option
of a pyeloplasty at the time of transplant. We have performed
o n es u c hp r o c e d u r ea to u rc e n t r e[ 22]. The donor had a
mildly hydronephrotic right kidney with a GFR of 107mL
per minute but only 32% function from the right kidney
(right kidney GFR: 35.3). The procedure was performed
without complication by anastomosing the pelvis of the
transplant to the recipient ureter, end to end over a ureteric
stent, which was removed 4 weeks later.
Based on our experience, we recommend that EVFUS is
a feasible and safe technique for stone extraction in donor
kidneys prior to LRRT. The procedure can be performed by
either the “Bench technique” or “On-Table technique,” the
main diﬀerence being the initial technique being performed
prior to renal allograft revascularisation versus the latter
which is performed following revascularisation.
5. Conclusion
In conclusion the donor is the most important in the
donor/recipient combination and the choice of kidney
should reﬂect this. Therefore the kidney with the stone
should be donated leaving the donor with the healthiest
kidney. In order to do this strategies should be evolved
to manage the stone in the transplanted kidney. One such
strategy is to utilise ureteroscopy and stone removal during
the ex vivo stage.
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